2021
DOI: 10.21037/atm-21-2700
|View full text |Cite
|
Sign up to set email alerts
|

Beta-1 syntrophin (SNTB1) regulates colorectal cancer progression and stemness via regulation of the Wnt/β-catenin signaling pathway

Abstract: Background: Beta-1 syntrophin (SNTB1) is an intracellular scaffold protein that provides a platform for the formation of signal transduction complexes, thereby modulating and coordinating various intracellular signaling events and crucial cellular processes. However, the physiological role of SNTB1 is poorly understood. This study aims to explore the role of SNTB1 in colorectal cancer (CRC) tumorigenesis and progression, with particular focus on SNTB1's expression pattern, clinical relevance, and possible mole… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 30 publications
(34 reference statements)
0
2
0
Order By: Relevance
“…Cytosolic NEU2 sialidase has a pivotal role in neuronal differentiation (Glanz et al 2019). The neural gene SNTB1 is related to neural precursor cell proliferation (Liang et al 2021). DOC2B participates in neuronal activity and neurotransmitter release (Adiga et al 2022).…”
Section: Discussionmentioning
confidence: 99%
“…Cytosolic NEU2 sialidase has a pivotal role in neuronal differentiation (Glanz et al 2019). The neural gene SNTB1 is related to neural precursor cell proliferation (Liang et al 2021). DOC2B participates in neuronal activity and neurotransmitter release (Adiga et al 2022).…”
Section: Discussionmentioning
confidence: 99%
“…In summary, in our study we highlighted the importance of 15 MEGs as prognostic markers for colon cancer progression. Four of them (SNTB1, ATAD2, HOXB8 and ITGBL1) have been indicated to be associated with the development of colon cancer (62)(63)(64)(65). We further identified 51 MEPs that were mapped into two groups according to their perturbation rate across colon cancer stages.…”
Section: Discussionmentioning
confidence: 99%